Volume 5, Issue 1, January 2017, Pages: 8-11
Received: Jan. 10, 2017;
Accepted: Feb. 10, 2017;
Published: Mar. 18, 2017
Views 2084 Downloads 150
Yusuf Hussaini, Department of Science Laboratory Technology, School/Faculty of Applied Sciences, Federal Polytechnic Nasarawa, Nasarawa, Nigeria
Justina A. Adegda, Department of Science Laboratory Technology, School/Faculty of Applied Sciences, Federal Polytechnic Nasarawa, Nasarawa, Nigeria
Ademu Abdulkadir, Department of Science Laboratory Technology, School/Faculty of Applied Sciences, Federal Polytechnic Nasarawa, Nasarawa, Nigeria
Abubakar Suleiman, Department of Science Laboratory Technology, School/Faculty of Applied Sciences, Federal Polytechnic Nasarawa, Nasarawa, Nigeria
Salawu E. Murtala, Department of Science Laboratory Technology, School/Faculty of Applied Sciences, Federal Polytechnic Nasarawa, Nasarawa, Nigeria
Yakubu Jibrin, Department of Science Laboratory Technology, School/Faculty of Applied Sciences, Federal Polytechnic Nasarawa, Nasarawa, Nigeria
Aliyu Yakubu, Department of Science Laboratory Technology, School/Faculty of Applied Sciences, Federal Polytechnic Nasarawa, Nasarawa, Nigeria
Trichomonasvaginalis, the etiologic agent of Trichomoniasis is transmitted by sexual intercourse, and is associated with the presence of other sexually transmitted diseases. In Nigeria, Trichomonasvaginalis infections are not reportable to health agencies and there is dearth of data on the actual prevalence. This cohort study determines the prevalence of Trichomonasvaginalis among female patients attending General Hospital Nasarawa, NasarawaState.Wet mount of all swab samples was made to check for the presence of motility. Out of 100 vaginal swabs samples analyzed, an overallprevalence of 12.0% was recorded. The highest prevalence of 16.67% was recorded for the 31-35 years old, while the lowest prevalence of 7.67% was recorded for16-20 years old. 13.2% prevalence was recorded in single women while 8.70% prevalence was recorded in married women. Those with three or more sex partners had 75% prevalence, 50% prevalencewas reported for those with two sex partners, while 3.6% was reported for those with one sex partner Trichomoniasis remained endemic in many developing countries where control may only be possible by regular screening and treatment. Sexual promiscuity and age were important predisposing factors of infection distribution in the studied population.
Justina A. Adegda,
Salawu E. Murtala,
Prevalence of Trichomonasvaginalis Among Female Patients Attending the General Hospital Nasarawa, Nasarawa State, Cell Biology.
Vol. 5, No. 1,
2017, pp. 8-11.
World Health Organization. Global prevalence and incidence of selected curable sexually transmitted diseases: overview and estimates. WHO/GPA/STD/95. Geneva: WHO, 1995.
Heine P, McGregor JA. Trichomonasvaginalis: a reemerging pathogen. ClinObstetGynecol1993; 36: 137–44.
Cotch MF, Pastorek JG, 2nd, Nugent RP, et al. Trichomonasvaginalis associated with low birthweight and preterm delivery. The Vaginal Infections and Prematurity Study Group. Sex TransmDis 1997; 24: 353–60.
terMeulen J, Mgaya HN, Chang-Claude J, et al. Risk factors for HIV infection in gynaecologicalinpatients in Dar es Salaam, Tanzania, 1988–1990. East Afr Med J 1992; 69: 688–92.
Laga M, Manoka A, Kivuvu M, et al. Non-ulcerative sexually transmitted diseases as risk factors forHIV-1 transmission in women: results from a cohort study. AIDS 1993; 7: 95–102.
Ghys PD, Diallo MO, Ettiegne-Traore V, et al. Genital ulcers associated with humanimmunodeficiency virus-related immunosuppression in female sex workers in Abidjan, IvoryCoast. J Infect Dis 1995; 172: 1371–4.
Sorvillo F, Kerndt P. Trichomonasvaginalis and amplification of HIV-1 transmission [letter]. Lancet1998; 351: 213–4.
Hardy PH, Hardy JB, Nell EE, et al. Prevalence of six sexually transmitted disease agents arising inpregnant inner-city adolescents and pregnancy outcome. Lancet 1984; 2: 333–7.
Carey JC, Klebanoff MA, Hauth JC, et al. Metronidazole to prevent preterm delivery in pregnantwomen with asymptomatic bacterial vaginosis. National Institute of Child Health and HumanDevelopment Network of Maternal-Fetal Medicine Units [see comments]. N Engl J Med2000; 342: 534–40.
Ali V, Nozaki T. Current therapeutics, their problems, and sulfur-containing-amino-acidmetabolism as a novel target against infections by “amitochondriate” protozoan parasites.ClinMicrobiol Rev. 2007; 20(1): 164–87.
Schwebke JR, Burgess D. Trichomoniasis. ClinMicrobiol Rev. 2004;17(4):794–803.
Edrissian GH, Rezaeian M, Ghorbani M, Keshavarz H, Mohebali M. 1st ed. Tehran University ofMedical Sciences; 2007. Medical Protozoology.
Petrin D, Delgaty K, Bhatt R, Garber G. Clinical and microbiological aspects of Trichomonasvaginalis. ClinMicrobiol Rev. 1998; 11(2): 300–17.
Khan NA. Emerging Protozoan Pathogenes. 1st ed. Taylor & Francis group; 2008.
Conrad M, Zubacova Z, Dunn LA, Upcroft J, Sullivan SA, Tachezy J, Carlton JM. Microsatellitepolymorphism in the sexually transmitted human pathogen Trichomonasvaginalis indicates agenetically diverse parasite. Pathogen Trichomonasvaginalis indicates a genetically diverseparasite. MolBiochem Parasitol. 2011; 175: 30–38.
Kassem HH, Majoud OA. Trichomoniasis among women with vaginal discharge in Benghazi city, Libya. J Egypt SocParasitol. 2006; 36(3): 1007–16.].
Mahafzah AM, Al-Ramahi MQ, Asa'd AM, El-Khateeb MS. Prevalence of sexually transmittedinfections among sexually active Jordanian females. Sex Transm Dis. 2008; 35(6): 607–10.
Selvitopu A, Ozcelik S, Degerli S. The incidence of Trichomonasvaginalis in vaginal specimens fromgynecologic patients. TurkiyeParazitolDerg. 2006; 30(3): 175–7.
Madani TA. Sexually transmitted infections in Saudi Arabia. BMC Infect Dis. 2006; 6: 3.
Sutton M, Sternberg M, Koumans EH, McQuillan G, Berman S, Markowitz L. The prevalence ofTrichomonasvaginalis infection among reproductive-age women in the United States, 2001-2004. Clin Infect Dis. 2007; 45: 1319-26.
Lazenby GB, Taylor PT, Badman BS, McHaki E, Korte JE, Soper DE, et al. An association betweenTrichomonasvaginalis and high-risk human papillomavirus in rural Tanzanian womenundergoing cervical cancer screening. ClinTher. 2014; 36: 38-45.
Miller M, Liao Y, Gomez AM, Gaydos CA, D'Mellow D. Factors associated with the prevalence andincidence of Trichomonasvaginalis infection among African American women in New York citywho use drugs. J Infect Dis. 2008; 197: 503-9.
Simhan HN, Anderson BL, Krohn MA, Heine P, Martinez de Tejada B, Landers DV, et al. Hostimmune consequences of asymptomatic Trichomonasvaginalis infection in pregnancy. Am JObstetGynecol. 2007; 196: 59.e1-5.
Rocha DA, Filho RA, Mariño JM, dos Santos CM. "Hidden" sexually transmitted infections amongwomen in primary care health services, Amazonas, Brazil. Int J STD AIDS. 2014; 25: 878-86.
Silva LC, Miranda AE, Batalha RS, Monte RL, Talhari S. Trichomonasvaginalis and associatedfactors among women living with HIV/AIDS in Amazonas, Brazil. Braz J Infect Dis.2013; 17: 701-3.
Souza RP, de Abreu AL, Ferreira ÉC, Rocha-Brischiliari SC, de B Carvalho MD, Pelloso SM, et al.Simultaneous detection of seven sexually transmitted agents in human immunodeficiency virus-infected Brazilian women by multiplex polymerase chain reaction. Am J Trop Med Hyg. 2013; 89: 1199-202.
Miranda AE, Pinto VM, Gaydos CA. Trichomonasvaginalis infection among young pregnantwomen in Brazil. Braz J Infect Dis. 2014; 18: 669-71.
Oliveira FA, Pfleger V, Lang K, Heukelbach J, Miralles I, Fraga F, et al. Sexually transmittedinfections, bacterial vaginosis, and candidiasis in women of reproductive age in rural NortheastBrazil: a population-based study. MemInstOswaldo Cruz. 2007; 102: 751-6.